Form D · Biotechnology
Clear Creek Bio, Inc.
Cambridge, MA · CIK 0001739831
Offering snapshot reported Oct 11, 2019 · SEC filing
- Reported sold
- $1.03M Offering amount: $1.63M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 11, 2019 | Initial | $1,026,667 | No comparison | 3 | SEC filing |
| May 7, 2018 | Initial | $6,119,999 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-350837
Source: Form D, filed Oct 11, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Burt Adelman | Director |
| Vikram S. Kumar | Director, Executive |
| Andrew Levin | Director |
| David Scadden | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
585 Massachusetts Avenue, 4 Th Floor
Cambridge, MA, 02139
Cambridge, MA, 02139